Medical researchers are often interested to investigate the relationship between explicative variables and times-to-events such as disease progression or death. Such multiple times-to-events can be studied using multistate models. For chronic diseases, it may be relevant to consider semi-Markov multistate models because the transition intensities between two clinical states more likely depend on the time already spent in the current state than on the chronological time. When the cause of death for a patient is unavailable or not totally attributable to the disease, it is not possible to specifically study the associations with the excess mortality related to the disease. Relative survival analysis allows an estimate of the net survival in the hypothetical situation where the disease would be the only possible cause of death. In this paper, we propose a semi-Markov additive relative survival (SMRS) model that combines the multistate and the relative survival approaches. The usefulness of the SMRS model is illustrated by two applications with data from a French cohort of kidney transplant recipients. Using simulated data, we also highlight the effectiveness of the SMRS model: the results tend to those obtained if the different causes of death are known.

1. Cox, DR, Oakes, D. Analysis of survival data, New York: Chapman and Hall, 1984.
Google Scholar
2. Hougaard, P . Multi-state models: a review. Lifetime Data Anal 1999; 5(3): 239264.
Google Scholar | Crossref | Medline | ISI
3. Putter, H, Fiocco, M, Geskus, RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med 2007; 26(11): 23892430.
Google Scholar | Crossref | Medline | ISI
4. Meira-Machado, L, de Uña-Álvarez, J, Cadarso-Suárez, C, et al. Multi-state models for the analysis of time-to-event data. Stat Methods Med Res 2009; 18(2): 195222.
Google Scholar | SAGE Journals | ISI
5. Dantal, J, Hourmant, M, Cantarovich, D, et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet 1998; 351(9103): 623628.
Google Scholar | Crossref | Medline | ISI
6. Hakulinen, T, Tenkanen, L. Regression analysis of relative survival rates. J R Stat Soc Ser C Appl Stat 1987; 36: 309317.
Google Scholar | Crossref | ISI
7. Esteve, J, Benhamou, E, Croasdale, M, et al. R : elements for further discussion. Stat Med 1990; 9(5): 529538.
Google Scholar | Crossref | Medline | ISI
8. Perme, MP, Stare, J, Estève, J. On estimation in relative survival. Biometrics 2012; 68(1): 113120.
Google Scholar | Crossref | Medline | ISI
9. Belot, A, Remontet, L, Launoy, G, et al. Competing risk models to estimate the excess mortality and the first recurrent-event hazards. BMC Med Res Methodol 2011; 11: 7878.
Google Scholar | Crossref | Medline | ISI
10. Huszti, E, Abrahamowicz, M, Alioum, A, et al. Relative survival multistate Markov model. Stat Med 2012; 31(3): 269286.
Google Scholar | Crossref | Medline | ISI
11. Lagakos, S, Sommer, C, Zelen, M. Semi-Markov models for partially censored data. Biometrika 1978; 65(2): 311317.
Google Scholar | Crossref | ISI
12. Huzurbazar, A . Multistate models, flowgraph models, and semi-Markov processes. Commun Stat Theory Methods 2004; 33(3): 457474.
Google Scholar | Crossref | ISI
13. Foucher, Y, Giral, M, Soulillou, JP, et al. A semi-Markov model for multistate and interval-censored data with multiple terminal events. application in renal transplantation. Stat Med 2007; 26(30): 53815393.
Google Scholar | Crossref | Medline | ISI
14. Foucher, Y, Giral, M, Soulillou, JP, et al. A flexible semi-Markov model for interval-censored data and goodness-of-fit testing. Stat Methods Med Res 2010; 19(2): 127145.
Google Scholar | SAGE Journals | ISI
15. Joly, P, Commenges, D. A penalized likelihood approach for a progressive three-state model with censored and truncated data: application to AIDS. Biometrics 1999; 55(3): 887890.
Google Scholar | Crossref | Medline | ISI
16. Foucher, Y, Mathieu, E, Saint-Pierre, P, et al. A semi-Markov model based on generalized weibull distribution with an illustration for HIV disease. Biom J 2005; 47(6): 825833.
Google Scholar | Crossref | Medline | ISI
17. Trebern-Launay, K, Giral, M, Dantal, J, et al. Comparison of the risk factors effects between two populations: two alternative approaches illustrated by the analysis of first and second kidney transplant recipients. BMC Med Res Methodol 2013; 13: 102102.
Google Scholar | Crossref | Medline | ISI
18. Giorgi, R, Abrahamowicz, M, Quantin, C, et al. A relative survival regression model using B-spline functions to model non-proportional hazards. Stat Med 2003; 22(17): 27672784.
Google Scholar | Crossref | Medline | ISI
19. Lau, B, Cole, SR, Gange, SJ. Competing risk regression models for epidemiologic data. Am J Epidemiol 2009; 170(2): 244256.
Google Scholar | Crossref | Medline | ISI
20. R Core Team . R: A language and environment for statistical computing, Vienna, Austria: R Foundation for Statistical Computing, 2013.
Google Scholar
21. Nelder, J, Mead, R. A simplex-method for function minimization. Computer journal 1965; 7(4): 308313.
Google Scholar | Crossref | ISI
22. Aalen, OO, Johansen, S. An empirical transition matrix for non-homogeneous Markov chains based on censored observations. Scand J Statist 1978; 5(3): 141150.
Google Scholar | ISI
23. Latouche, A, Boisson, V, Chevret, S, et al. Misspecified regression model for the subdistribution hazard of a competing risk. Stat Med 2007; 26(5): 965974.
Google Scholar | Crossref | Medline | ISI
24. Hall, EC, Engels, EA, Pfeiffer, RM, et al. Association of antibody induction immunosuppression with cancer after kidney transplantation. Transplantation 2015; 99(5): 10511051. –7.
Google Scholar | Crossref | Medline | ISI
25. Yarlagadda, SG, Coca, SG, Formica, RN, et al. Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. Nephrol Dial Transplant 2009; 24(3): 10391047.
Google Scholar | Crossref | Medline | ISI
26. Le Teuff, G, Abrahamowicz, M, Bolard, P, et al. Comparison of Cox’s and relative survival models when estimating the effects of prognostic factors on disease-specific mortality: a simulation study under proportional excess hazards. Stat Med 2005; 24(24): 38873909.
Google Scholar | Crossref | Medline | ISI
27. Tsiatis, A . A nonidentifiability aspect of the problem of competing risks. Proc Natl Acad Sci USA 1975; 72(1): 2022.
Google Scholar | Crossref | Medline | ISI
28. Latouche, A, Beyersmann, J, Fine, JP. Comments on ‘Analysing and interpreting competing risk data’. Stat Med 2007; 26(19): 36763679.
Google Scholar | Crossref | Medline | ISI
29. Talback, M, Dickman, PW. Estimating expected survival probabilities for relative survival analysis – exploring the impact of including cancer patient mortality in the calculations. Eur J Cancer 2011; 47(17): 26262632.
Google Scholar | Crossref | Medline | ISI
Access Options

My Account

Welcome
You do not have access to this content.



Chinese Institutions / 中国用户

Click the button below for the full-text content

请点击以下获取该全文

Institutional Access

does not have access to this content.

Purchase Content

24 hours online access to download content

Research off-campus without worrying about access issues. Find out about Lean Library here

Your Access Options


Purchase

SMM-article-ppv for $41.50
Single Issue 24 hour E-access for $543.66

Cookies Notification

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more.
Top